Journal decision profile

AIDS Research and Treatment

Medicine

AIDS Research and Treatment's 2026 Journal Metrics Score is 1.1, ranking Q3 in Infectious Diseases and 1 other subfield. Two-year citation average from OpenAlex data, updated August 2026.

Hindawi Publishing CorporationUnited KingdompISSN 2090-1240eISSN 2090-1259
Checking system sharing availability.Visit homepage

Bookmark this page — track observed submission-to-acceptance timing, FWCI and field-normalized citation data for this journal in one view.

Journal Metrics Score
i
Journal Metrics ScoreThe raw score is citations received in the latest complete year by works from the two previous years, divided by the number of those works. It is calculated from OpenAlex open data (CC0) and is not a percentage grade.
2026
1.1

Journal Metrics Score 2026 · 2021–2024 window citedness 2.21.

Submission-to-acceptance
i
Submission-to-acceptanceCalendar days between the received and accepted dates reported in recent PubMed records. This interval includes editorial handling and author revisions, so it is not time to first decision or pure peer-review time.
PUBMED
190 daysmedian

Middle 50%: 156–293 days

39 of 39 PubMed-indexed articles · 100% coverage · 2024–2025

Indicative APC
i
Indicative APCThis journal-level estimate comes from the OpenAlex source record. It is not a verified quote and may exclude taxes, waivers, society discounts, or article-type charges. Check the journal's official website before deciding.
OPENALEX · VERIFY
$1,000

Journal-level estimate only. Verify current charges, taxes, waivers, discounts, and article-type fees with the journal.

Free preview · no sign-in

Does your manuscript fit AIDS Research and Treatment?

Paste your title to see which of this journal's published topics it overlaps with. Your title stays in your browser for this preview and is not sent anywhere.

Want ranked journals with fit reasons, risks and a submission strategy instead? See a sample AI report.

At a glance

Journal decision profile

Each spoke is a 0–100 percentile within a comparable journal cohort—not a percentage grade or a single black-box rating.

Relative profile

Metrics ScoreThe raw 2026 Journal Metrics Score is the recent two-year citation average shown above. The radar converts it to a 0–100 cohort percentile: farther out means a higher score than more comparable journals. It is not a percentage grade.iSource outputThe raw rank compares lifetime output inside the journal’s leading-topic source set. The radar then compares that rank position across Decision Profile journals in the same primary OpenAlex field; when that field has too few profiles, it uses the broader profile set. Farther out means relatively more output, not better research quality.iTop 10% shareThe share of recent papers in the global top 10% for citations after comparing papers of the same type, publication year, and subfield. The radar converts that share to a 0–100 cohort percentile; it does not predict how a new paper will perform.iMedian FWCICitation performance of the middle recent paper after field, year, and work type are considered. A raw FWCI of 1.0 is the expected citation level for comparable papers; the radar shows its 0–100 cohort percentile.iSubmission-to-acceptanceCalendar days from the received date to the accepted date in recent PubMed records. This includes editorial handling and author revisions, so it is not the time to first decision and not pure peer-review time. The radar uses a 0–100 cohort percentile with shorter observed timing plotted farther out; it does not measure review quality.iOutput volumeAverage works published per year in the recent analysis window, converted to a 0–100 cohort percentile. Farther out means the journal publishes more papers; it does not mean those papers are better.i
Cost is intentionally excluded. Missing APC data is never converted to a zero-dollar fee or a fabricated cost score.

Raw values behind the shape

Always visible
Metrics Score
i
Metrics ScoreThe 2026 raw Journal Metrics Score shown above. The bar is its 0–100 percentile within the radar's comparable journal cohort; it is not a percentage score.
1.12026 · OPENALEX
Source output rank
i
Source output rankThis lifetime journal-wide output rank compares works published by the OpenAlex source with sources associated with the journal’s leading topic. More output does not mean higher quality.
#1148 / 4,245LIFETIME OUTPUT
Highly cited papers
i
Highly cited papersShare of recent works in the global top 10% for citations after comparing papers of the same type, publication year, and subfield.
2.9%FIELD-NORMALIZED TOP 10%
Field-normalized impact
i
Field-normalized impactCitation performance of the middle recent paper after field, year, and work type are considered. A raw FWCI of 1.0 is the expected level for comparable work.
0.70MEDIAN FWCI
Submission-to-acceptance
i
Submission-to-acceptanceReceived-to-accepted calendar days from qualified PubMed records. It includes editorial handling and author revisions; it is not time to first decision or pure peer-review time.
190 daysIQR 156–293 DAYS
Recent output
i
Recent outputAverage works published per year across the complete analysis window. This is a volume measure, not a quality score.
9 / yr2021–2024 AVG
Field-normalized top 10% share2.9%

1 of 34 works · same type, year & subfield

Field-normalized top 1% share0%

0 works · same type, year & subfield

Median FWCI0.70×

Below field-year expectation

Source output rank#1148

of 4,245 topic-associated OpenAlex sources by lifetime output

What does Median FWCI mean?

FWCI compares papers with the same publication year, type, and field. 1.0 is the world average; above 1.0 is above expectation. This journal's median is 0.70, so its typical recent paper runs about 30% below its field benchmark.

What does Top 10% Share mean?

2.9% of recent papers rank in the global top 10% after field normalization. This is easier to compare across specialties than raw citation totals.

Publishing pattern

Publication volume and article mix

Volume is separated from citation accumulation so newer papers are not presented as weaker simply because they are newer.

Works published by year

OpenAlex source records · 2016–2025

262016
252017
132018
172019
212020
32021
132022
112023
72024
342025

Recent work-type mix

34 OpenAlex works · 2021–2024

Article85.3%
Review8.8%
Paratext5.9%
OpenAlex article is broader than “original research.” PubMed Publication Types can add case-report and clinical-study detail.
Fit signals

Topics and research coverage

OpenAlex topics show the research communities this journal serves.

Leading OpenAlex topics

2021–2024 works
HIV/AIDS Research and Interventions20
HIV-related health complications and treatments6
Global Maternal and Child Health1
HIV Research and Treatment1
HIV/AIDS drug development and treatment1
Mobile Health and mHealth Applications1
Sleep and related disorders1
Tuberculosis Research and Epidemiology1
Methodology: OpenAlex snapshot 2026-10-27. FWCI, percentile badges, topics, and type mix use 34 works published 2021–2024. Radar normalization is versioned in the cached profile, and no cost score is assigned without reliable APC data.

Subject Category Quartiles

Quartiles computed within each OpenAlex subfield
CategoryQuartile
Infectious DiseasesQ3
VirologyQ4
General Health ProfessionsQ3

Is AIDS Research and Treatment a good journal?

A mid-ranked Q3 journal by citation data

By citation data, AIDS Research and Treatment is a mid-ranked journal: it is Q3 in Infectious Diseases and 1 other subfield, the third quarter of journals by score, below the subfield median, and ranks #4,133 of 6,272 Medicine journals by Journal Metrics Score (top 66%). AIDS Research and Treatment's 2026 Journal Metrics Score is 1.1. Recent papers took a median of 190 days from submission to acceptance, according to PubMed dates. OpenAlex lists an indicative article processing charge of $1,000 USD. OpenAlex classifies its papers in subfields including Infectious Diseases, Virology, and General Health Professions, so check that your topic fits its scope.

Best quartile
Q3
Infectious Diseases
Rank in Medicine
#4,133 of 6,272
Top 66%
2026 Journal Metrics Score
1.1
Acceptance rate
Not published
By the journal or publisher
Submission to acceptance
190 days
Median, PubMed records
Open access fee (APC)
$1,000
OpenAlex, verify with the journal
Papers published in 2025
34
OpenAlex works

Check before you submit

  • Confirm the current article processing charge, waivers, and any institutional agreement on the journal website; the OpenAlex figure is indicative.
  • Confirm the journal is indexed where your institution or funder requires (for example Scopus or PubMed) before you submit.

Verdict from citation data only: quartile and field rank by Journal Metrics Score (OpenAlex), publisher-reported acceptance rates, and PubMed submission and acceptance dates. See how we rank journals and how to verify indexing.

Q3
Subfield Quartile
N/A
CAS Block

Ranking and source check

#4,133
of 6,272 Medicine field journals
#477
among Q3 Medicine journals

Confirm the exact title and ISSNs against the publisher homepage before a high-stakes submission decision.

Journal Details

OpenAlex Works
406
H-Index
46
Fully Open Access
Yes
Recent OA Works
405
Subject Areas
Infectious DiseasesVirologyGeneral Health Professions

Source: the current OpenAlex source record. OpenAlex works can include multiple work types. Fully Open Access is a source-level flag. Recent OA Works is summed from OpenAlex's counts_by_year series (up to the latest ten years); it is not a lifetime OA percentage. Any APC shown here is an indicative OpenAlex value—verify current charges on the journal's official website.

How to submit to AIDS Research and Treatment

  1. 1

    Check the scope

    OpenAlex classifies AIDS Research and Treatment's papers in subfields including Infectious Diseases, Virology, and General Health Professions. Read the aims and scope page and a few recent papers close to your topic before you prepare the manuscript.

  2. 2

    Follow the author guidelines

    Article types, word and figure limits, reference style, and the required statements (data availability, ethics, conflicts of interest, author contributions) are set by the journal. Prepare the cover letter and files to match them.

    AIDS Research and Treatment homepage ↗
  3. 3

    Submit online

    Use the submit link in AIDS Research and Treatment's author guidelines; Hindawi Publishing Corporation runs the submission site. Every author usually needs an ORCID iD, and the corresponding author needs an account on the submission site.

  4. 4

    Plan for costs

    OpenAlex lists an indicative article processing charge of $1,000 USD for this open-access journal. Check the current fee, waivers, and any institutional agreement on the journal website.

  5. 5

    Know what to expect

    Recent accepted papers took a median of 190 days from submission to acceptance, including revisions (PubMed dates). AIDS Research and Treatment does not publish an acceptance rate.

New on PubMed

What's new in your field?

Type a topic to see the newest PubMed papers from the past week and the big picture of what they found, summarized by Claude on the Pro plan. Get a free weekly email to keep up.

See a demo:GLP-1CRISPRLong COVID

Reviewer Two · coming soon

Know what reviewers will say before you submit to AIDS Research and Treatment

An AI pre-submission report on your manuscript: the objections a tough reviewer is likely to raise, desk-rejection risks, and better-fit journals from our data. $29 per report.

See what the report covers

Common questions about AIDS Research and Treatment

Is AIDS Research and Treatment a good journal?

By citation data, AIDS Research and Treatment is a mid-ranked journal: it is Q3 in Infectious Diseases and 1 other subfield, the third quarter of journals by score, below the subfield median, and ranks #4,133 of 6,272 Medicine journals by Journal Metrics Score (top 66%). AIDS Research and Treatment's 2026 Journal Metrics Score is 1.1. Recent papers took a median of 190 days from submission to acceptance, according to PubMed dates. OpenAlex lists an indicative article processing charge of $1,000 USD. OpenAlex classifies its papers in subfields including Infectious Diseases, Virology, and General Health Professions, so check that your topic fits its scope.

What is AIDS Research and Treatment's Journal Metrics Score in 2026?

AIDS Research and Treatment's 2026 Journal Metrics Score is 1.1, from the August 2026 data release. The score is a two-year citation average computed from OpenAlex (CC0) data: citations received in the most recent complete year to works published in the two prior years, divided by the number of those works.

What is the acceptance rate of AIDS Research and Treatment?

We have not found an official acceptance rate published by AIDS Research and Treatment or its publisher, and Journal Metrics does not estimate one because submission counts are not public. What recent PubMed records do show is speed: accepted papers took a median of 190 days from submission to acceptance. To judge selectivity, compare AIDS Research and Treatment's quartile and score with similar journals, or ask the editorial office.

What quartile is AIDS Research and Treatment in?

AIDS Research and Treatment's best quartile is Q3. By OpenAlex subfield: Q3 in Infectious Diseases; Q4 in Virology; Q3 in General Health Professions. Quartiles rank journals by Journal Metrics Score within each subfield.

Is the Journal Metrics Score the same as other journal citation metrics?

No. Journal Metrics computes the score independently from OpenAlex open data. Other providers use different citation databases, document types, and counting rules, so their published figures for AIDS Research and Treatment will not match this score exactly. Compare journals using one source at a time.

How long does AIDS Research and Treatment take from submission to acceptance?

Across 39 recent PubMed records with both dates, AIDS Research and Treatment took a median of 190 days from submission to acceptance; the middle half took 156–293 days. This interval includes editorial handling and revisions, so it is not the time to a first decision.

How much does it cost to publish in AIDS Research and Treatment?

OpenAlex lists an indicative article processing charge of $1,000 USD for AIDS Research and Treatment. This journal-level estimate may exclude taxes, waivers, discounts, or article-type fees, so confirm the current charge on the journal's website.

Which journals are alternatives to AIDS Research and Treatment?

Comparable journals include Hiv Aids-Research and Palliative Care, Jaids-Journal of Acquired Immune Deficiency Syndromes, Aids Research and Therapy, and Hiv Medicine. Compare their scores, acceptance times, and costs in the recommended alternatives on this page before choosing where to submit.

How do I submit a paper to AIDS Research and Treatment?

Submit online through the link in AIDS Research and Treatment's author guidelines on the journal homepage. Before submitting, check the scope, follow the author guidelines for article type, length, and required statements, and prepare a cover letter. Accepted papers took a median of 190 days from submission to acceptance in recent PubMed records.

Cite an article from this journal
Back to Search